McKesson Corporation vs Under Armour Inc Class A — how do they compare? McKesson Corporation trades at $898 (market cap $105.14B), while Under Armour Inc Class A trades at $5.24 (market cap $2.26B). The key difference: McKesson Corporation is far larger — about 46.5× Under Armour Inc Class A's market cap, and McKesson Corporation pays a 0.42% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.
| MCK | UA | |
|---|---|---|
Market Cap | $105.14B | $2.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $995.69 | $7.88 |
52-Week Low | $659.01 | $3.96 |
Enterprise Value | $111.67B | $3.24B |
Dividend Yield | 0.42% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Under Armour (UA) trades at $5.925, down 5.2% with bearish technical signals. The company reported mixed Q2 2026 results with an earnings beat but faces revenue declines and negative profitability metrics. Recent news highlights lowered fiscal 2027 revenue outlook due to softer consumer demand in key markets. Cash flow remains negative with significant operational challenges.
The outlook remains challenging with declining revenue trends and negative margins. While analyst consensus shows mixed sentiment, the stock faces headwinds from competitive pressures and execution risks. Investment opportunity exists only for those betting on a successful turnaround despite current fundamental weaknesses.
Trailing returns across standard periods
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →